Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) closed at $9.69 down -4.15% from its previous closing price of $10.11. In other words, the price has decreased by -$4.15 from its previous closing price. On the day, 1.35 million shares were traded. AUPH stock price reached its highest trading level at $10.15 during the session, while it also had its lowest trading level at $9.68.
Ratios:
For a deeper understanding of Aurinia Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 48.24. For the most recent quarter (mrq), Quick Ratio is recorded 5.11 and its Current Ratio is at 5.60. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.19.
Oppenheimer Upgraded its Perform to Outperform on December 10, 2021, whereas the target price for the stock was revised from $33 to $31.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 09 ’24 when TANG KEVIN bought 500,000 shares for $9.09 per share. The transaction valued at 4,545,000 led to the insider holds 8,429,500 shares of the business.
TANG KEVIN bought 400,000 shares of AUPH for $3,604,000 on Dec 06 ’24. The Director now owns 7,929,500 shares after completing the transaction at $9.01 per share. On Dec 05 ’24, another insider, TANG KEVIN, who serves as the Director of the company, bought 300,000 shares for $8.91 each. As a result, the insider paid 2,673,000 and bolstered with 7,529,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUPH now has a Market Capitalization of 1447540480 and an Enterprise Value of 1127023104. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.30 while its Price-to-Book (P/B) ratio in mrq is 3.57. Its current Enterprise Value per Revenue stands at 5.114 whereas that against EBITDA is 2276.814.
Stock Price History:
Over the past 52 weeks, AUPH has reached a high of $10.67, while it has fallen to a 52-week low of $4.71. The 50-Day Moving Average of the stock is 21.87%, while the 200-Day Moving Average is calculated to be 54.88%.
Shares Statistics:
For the past three months, AUPH has traded an average of 1.28M shares per day and 1737420 over the past ten days. A total of 143.11M shares are outstanding, with a floating share count of 128.68M. Insiders hold about 10.13% of the company’s shares, while institutions hold 39.33% stake in the company. Shares short for AUPH as of 1732838400 were 6222735 with a Short Ratio of 4.88, compared to 1730332800 on 7344712. Therefore, it implies a Short% of Shares Outstanding of 6222735 and a Short% of Float of 4.37.
